Key facts
- It has raised $120K; the latest was Seed Round ($120K) in Sep 2025.
- Notable investors include Antler, MassChallenge.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Tint Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Tint Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tint Biotech
Developer of sustainable natural pigments designed to provide purity, stable colorants for food, cosmetics, and nutraceutical applications. The company engages in proprietary biotechnology and a zero-waste, circular biorefinery process to extract and purify pigments, enabling manufacturers seeking cleaner, greener alternatives to synthetic dyes.
- Sector
- Materials and Resources
- HQ
- Almeria, Spain
- Founded
- 2025
- Website
- tint.bio/
- Ownership
- Privately Held (backing)
Tint Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tint Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tint Biotech in its N-PORT filings yet. We sweep new filings monthly.